Your browser doesn't support javascript.
loading
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.
Baldwin, Susan L; Ching, Lance K; Pine, Samuel O; Moutaftsi, Magdalini; Lucas, Elyse; Vallur, Aarthy; Orr, Mark T; Bertholet, Sylvie; Reed, Steven G; Coler, Rhea N.
Affiliation
  • Baldwin SL; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Ching LK; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Pine SO; Allergan, Inc. 2525 Dupont Dr., Irvine, CA USA 92612.
  • Moutaftsi M; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Lucas E; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Vallur A; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Orr MT; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Bertholet S; Novartis Vaccines and Diagnostics, Siena, Italy.
  • Reed SG; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA, USA 98102.
  • Coler RN; Department of Global Health, University of Washington, Seattle, WA, USA 98195.
J Immunol ; 191(5): 2514-2525, 2013 Sep 01.
Article in En | MEDLINE | ID: mdl-23904160
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Adjuvants, Immunologic / Immunization, Secondary / CD8-Positive T-Lymphocytes / Tuberculosis Vaccines Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Immunol Year: 2013 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Adjuvants, Immunologic / Immunization, Secondary / CD8-Positive T-Lymphocytes / Tuberculosis Vaccines Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Immunol Year: 2013 Document type: Article Country of publication: United States